ALCYSTA

About

ALCYSTA contains Cysteamine Bitartrate, a medication specifically indicated for the treatment of nephropathic cystinosis, a rare genetic metabolic disorder characterized by the accumulation of the amino acid cystine within lysosomes in various organs, including the kidneys, eyes, and thyroid gland. This accumulation leads to progressive organ damage and dysfunction. Cysteamine works by reacting with cystine inside the lysosomes to form a mixed disulfide, which can then be transported out of the lysosomes by a normal amino acid carrier. This process effectively reduces the intralysosomal cystine accumulation, thereby slowing the progression of kidney failure and other complications associated with the disease.

Early and consistent treatment with ALCYSTA is crucial for managing nephropathic cystinosis. It helps to preserve kidney function, delay the need for kidney transplantation, and mitigate other systemic manifestations of the disease, such as growth retardation, photophobia, and thyroid dysfunction. The medication requires careful monitoring of cystine levels in white blood cells to ensure optimal dosing and therapeutic efficacy. Its use represents a significant advancement in improving the long-term prognosis and quality of life for individuals affected by this debilitating condition.

Uses

• Treats nephropathic cystinosis.
• Reduces intralysosomal cystine accumulation.
• Delays progression of kidney failure.
• Mitigates systemic complications of cystinosis.

Directions For Use

Take orally as directed by your physician, usually every 6 hours. Swallow capsules whole; do not chew or crush.

Benefits

• Slows the progression of kidney damage.
• Helps preserve kidney function.
• Reduces cystine crystal formation in the eyes.
• Improves growth in affected children.
• Decreases the severity of systemic symptoms.
• Enhances overall quality of life for patients.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Bad breath/body odor
• Lethargy
• Headache
• Dizziness
• Rash
• Fever
• Anorexia
• Tremors

Safety Measures

• Alcohol - No specific interaction with alcohol is generally noted, but alcohol should be consumed in moderation.
• Pregnancy - Use only if the potential benefit justifies the potential risk to the fetus; consult your doctor.
• Breastfeeding - It is not known if cysteamine is excreted in human milk; breastfeeding is generally not recommended.
• Liver - Use with caution in patients with liver impairment; monitor liver function tests regularly.
• Kidney - Specifically used for kidney disease in cystinosis; careful monitoring of kidney function is essential.
• Lung - No specific contraindications related to lung conditions are generally noted for cysteamine.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.